Clinical Trial Update: Evaluation of RC28-E Injection in Diabetic Retinopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for RC28-E injection in diabetic retinopathy, sponsor RemeGen Co., Ltd., status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• RC28-E

Snippet

Sponsor: RemeGen Co., Ltd. | Conditions: Diabetic Retinopathy | Phase 2 | Status: UNKNOWN